Clinical Trial Update: SGLT2 Inhibitors and Effects on Hematopoiesis, Inflammation and Metabolic Markers

View source ↗

Summary

A clinical trial update investigating the effects of SGLT2 inhibitors on hematopoiesis, inflammation, and metabolic markers in type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: University of Patras | Conditions: Diabetes Mellitus, Type 2 | Status: ACTIVE_NOT_RECRUITING